Srettha takes difficult collection on drugs, even disagrees with’ five- tablet rule’ for speed possession
As he announced a “get- challenging approach to illegal medicines,” Prime Minister Srettha Thavisin reiterated his desire for cannabis to be reclassified as a opioid by the end of 2024.
Mr. Srettha stated on his X profile that he wanted a rules limiting cannabis use only for medical and health reasons.
Thailand was one of the first Asian nations to outlaw cannabis in 2022. Without a thorough law, fun use rose while the intention was to promote medical use.
In its attempts to pass a marijuana act, the previous state failed. The former chancellor Cholnan Srikaew hoped to pass a fresh bill through Parliament before the end of 2024 thanks to the Ministry of Public Health.
In the cabinet reshuffle last week, Dr. Cholnan, who lost his job, proposed a bill that would obviously list approved medicinal uses for the plant as well as what types of consumption may be prohibited.
The new chancellor, Somsak Thepsuthin, said this week that he wanted to listen to people’s ideas first before making a final choice on the future of hemp. He claimed that it would not get longer.
However, Mr. Srettha asserted that all organizations must work together to solve the country’s drug problem because it is a significant national priority. Within 90 days, he claimed he wanted to see tangible benefits.
He also stated that he disagreed with the frequently detested “five-pill rule” in the health ministry’s meth ownership policy. The aim of the law, even introduced by Dr Cholnan, was to more plainly individual users from sellers.
The National Narcotics Act says simply that a” little number” should be considered as being for personal use, without specifying a range.
If someone consents to find medical care, they should not be prosecuted, according to Dr. Cholnan. Five tablets or less was required by the rules.
Instead of specifying a small quantity, Mr. Srettha made his position crystal clear:” Set the amount to get assumed to be in possession for use to be one product.”